Acurx PharmaceuticalsACXP
13F holders, Q3 2025 (September 30)1holders −30
0new positions
18sold out
$0.32avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, down 30 from Q2 2025. 0 opened new positions and 18 sold out. The largest holder was Osaic Holdings, Inc. ($2K).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 18 | $1.0M |
All 13F filers, Q2 2025 → Q3 2025: 1,973,251 shares sold, net −1,973,251 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | Reduce -27.5% | 7,582 | $2K |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.